Cell MedX Corp. (CMXC) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
820 - 1130 PENDER STREET, WEST VANCOUVER, BC V6E 4A4 |
| State of Incorp. | NV |
| Fiscal Year End | May 31 |
| Industry (SIC) | 59 - Miscellaneous Retail (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)Annual | Quarterly
| 5/31/2024 Q4 | 2/29/2024 Q3 | 11/30/2023 Q2 | 8/31/2023 Q1 | 5/31/2023 Q4 | 2/28/2023 Q3 | 11/30/2022 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 79,677 | 22,623 | 58,074 | 98,295 | 7,628 | 17,813 | |||
| Cash and cash equivalents | 79,677 | 22,623 | 58,074 | 98,295 | 7,628 | 17,813 | |||
| Other current assets | 2,241 | 260 | 4,252 | 4,975 | 6,268 | 6,209 | |||
| Total current assets: | 81,918 | 22,883 | 62,326 | 103,270 | 13,896 | 24,022 | |||
| Noncurrent Assets | |||||||||
| TOTAL ASSETS: | 81,918 | 22,883 | 62,326 | 103,270 | 13,896 | 24,022 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 290,156 | 656,507 | 412,574 | 444,824 | 430,196 | 452,119 | |||
| Accounts payable | 277,054 | 648,176 | 370,094 | 408,264 | 406,578 | 420,801 | |||
| Accrued liabilities | 13,102 | 8,331 | 42,480 | 36,560 | 23,618 | 31,318 | |||
| Total current liabilities: | 290,156 | 656,507 | 412,574 | 444,824 | 430,196 | 452,119 | |||
| Noncurrent Liabilities | |||||||||
| Other undisclosed liabilities | 501,708 | 1,891,868 | 2,121,117 | 2,043,926 | 1,888,386 | 1,771,238 | |||
| Total liabilities: | 791,864 | 2,548,375 | 2,533,691 | 2,488,750 | 2,318,582 | 2,223,357 | |||
| Equity | |||||||||
| Equity, attributable to parent | (1,151,439) | (2,891,985) | (2,837,858) | (2,751,973) | (2,671,179) | (2,565,828) | |||
| Common stock | 294,736 | 62,923 | 62,923 | 62,923 | 62,923 | 62,923 | |||
| Additional paid in capital | 8,663,581 | 7,272,701 | 7,272,701 | 7,272,701 | 7,272,701 | 7,272,701 | |||
| Accumulated other comprehensive income | 60,550 | 62,668 | 56,248 | 65,180 | 66,591 | 53,781 | |||
| Accumulated deficit | (10,170,306) | (10,290,277) | (10,229,730) | (10,152,777) | (10,073,394) | (9,955,233) | |||
| Other undisclosed equity | 441,493 | 366,493 | 366,493 | 366,493 | 366,493 | 366,493 | |||
| Total equity: | (709,946) | (2,525,492) | (2,471,365) | (2,385,480) | (2,304,686) | (2,199,335) | |||
| TOTAL LIABILITIES AND EQUITY: | 81,918 | 22,883 | 62,326 | 103,270 | 13,896 | 24,022 | |||
Income Statement (P&L) (USD)Annual | Quarterly
| 5/31/2024 Q4 | 2/29/2024 Q3 | 11/30/2023 Q2 | 8/31/2023 Q1 | 5/31/2023 Q4 | 2/28/2023 Q3 | 11/30/2022 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Cost of revenue (Cost of Goods and Services Sold) | (1,426) | |||||||
| Other undisclosed gross profit | (471) | 711 | 1,950 | |||||
| Gross profit: | (471) | 711 | 524 | |||||
| Operating expenses | (57,775) | (42,562) | (51,054) | (64,302) | (106,543) | (132,573) | ||
| Operating loss: | (57,775) | (42,562) | (51,054) | (64,773) | (105,832) | (132,049) | ||
| Nonoperating income (expense) (Gain (Loss), Foreign Currency Transaction, before Tax) | 6,420 | (8,932) | (1,411) | 12,810 | 48,200 | |||
| Interest and debt expense | (9,771) | (17,985) | (25,899) | (14,610) | (12,329) | (10,764) | ||
| Loss from continuing operations: | (67,546) | (54,127) | (85,885) | (80,794) | (105,351) | (94,613) | ||
| Other undisclosed net income (loss) | 187,517 | (6,420) | 8,932 | 1,411 | (12,810) | (48,200) | ||
| Net income (loss) available to common stockholders, diluted: | 119,971 | (60,547) | (76,953) | (79,383) | (118,161) | (142,813) | ||
Comprehensive Income (USD)Annual | Quarterly
| 5/31/2024 Q4 | 2/29/2024 Q3 | 11/30/2023 Q2 | 8/31/2023 Q1 | 5/31/2023 Q4 | 2/28/2023 Q3 | 11/30/2022 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 119,971 | (60,547) | (76,953) | (79,383) | (118,161) | (142,813) | ||
| Comprehensive income (loss): | 119,971 | (60,547) | (76,953) | (79,383) | (118,161) | (142,813) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (2,118) | 6,420 | (8,932) | (1,411) | 12,810 | 48,200 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 117,853 | (54,127) | (85,885) | (80,794) | (105,351) | (94,613) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.